Thus, our findings suggested that anti–pCTS-L pAbs conferred protection against lethal sepsis partly by attenuating pCTS-L–induced dysregulated inflammation orchestrated by both TLR4 and RAGE receptors. Here, TLR4 is linked to Sepsis.